Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06371235

Study of the Transmission of Anti-interferon Type 1 Alpha Autoantibodies From Mother to Child Via the Placental Barrier

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
CerbaXpert · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of the study is to evaluate the frequency of placental transfer of self-Ab directed against the mother's IFN alpha in the newborn, in all women suffering from a pathology frequently associated with the presence of these autoantibodies and in those seropositive during the pregnancy.

Conditions

Interventions

TypeNameDescription
OTHERPregiferonThis Study aims to study the transmission of anti-interferon alpha autoantibodies from mother to child viaplacental barrier

Timeline

Start date
2024-09-01
Primary completion
2024-09-01
Completion
2027-03-01
First posted
2024-04-17
Last updated
2024-04-17

Source: ClinicalTrials.gov record NCT06371235. Inclusion in this directory is not an endorsement.